Bio-Rad Laboratories (BIO)
Supplies droplet digital PCR, clinical-laboratory systems, reagents, controls, and recurring consumables.
$379.57
After hours−0.05 (−0.01%)
At close$379.62(+0.61%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 632 | 681 | 611 | 638 | 650 | 667 | 585 | 652 | 653 | 693 | 592 | 651 |
| Cost of revenue | 296 | 315 | 284 | 283 | 294 | 326 | 279 | 306 | 310 | 348 | 283 | 305 |
| Gross profit | 336 | 366 | 326 | 355 | 356 | 342 | 306 | 345 | 343 | 345 | 309 | 346 |
| 245 | 268 | 274 | 254 | 291 | 284 | 282 | 268 | 278 | 282 | 275 | 273 | |
| Research & development | 44 | 62 | 64 | 59 | 91 | 80 | 74 | 61 | 71 | 66 | 63 | 61 |
| Selling, general & administrative | 201 | 206 | 210 | 196 | 200 | 204 | 209 | 208 | 207 | 217 | 212 | 212 |
| Other expenses | 0 | 0 | 0 | −2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income | 91 | 98 | 52 | 101 | 64 | 58 | 24 | 77 | 66 | 62 | 34 | 73 |
| 46 | 331 | 439 | −2,888 | 797 | −967 | 60 | 337 | −498 | 867 | −724 | 470 | |
| Interest income | 17 | 17 | 34 | 17 | 16 | 16 | 36 | 15 | 14 | 31 | 21 | 22 |
| Interest expense | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 13 | 12 | 12 | 12 | 0 |
| Other non-operating income | −59 | −343 | −451 | 2,876 | −809 | 955 | −72 | −350 | 485 | −879 | 712 | −470 |
| Income before tax | 137 | 428 | 491 | −2,786 | 862 | −909 | 83 | 414 | −431 | 929 | −690 | 542 |
| Income tax expense | 31 | 79 | 107 | −621 | 208 | −193 | 19 | 96 | −89 | 209 | −163 | 171 |
| Net income from continuing operations | 106 | 350 | 384 | −2,165 | 653 | −716 | 64 | 318 | −342 | 720 | −527 | 371 |
| Net income | 106 | 350 | 384 | −2,165 | 653 | −716 | 64 | 318 | −342 | 720 | −527 | 371 |
| EPS, basic | $3.65 | $12.15 | $13.46 | −$76.26 | $23.37 | −$25.57 | $2.29 | $11.67 | −$12.70 | $26.69 | −$19.55 | $13.89 |
| EPS, diluted | $3.64 | $12.14 | $13.45 | −$76.26 | $23.34 | −$25.57 | $2.29 | $11.67 | −$12.70 | $26.65 | −$19.55 | $13.85 |
| Weighted average shares, basic | 29 | 29 | 29 | 28 | 28 | 28 | 28 | 27 | 27 | 27 | 27 | 27 |
| Weighted average shares, diluted | 29 | 29 | 29 | 28 | 28 | 28 | 28 | 27 | 27 | 27 | 27 | 27 |
| EBITDA | 198 | 494 | 551 | −2,727 | 923 | −847 | 134 | 477 | −365 | 994 | −637 | 542 |
| Depreciation & amortization | 48 | 53 | 48 | 47 | 49 | 49 | 38 | 51 | 54 | 52 | 41 | 0 |
| EBIT | 150 | 441 | 503 | −2,774 | 874 | −897 | 95 | 427 | −419 | 941 | −678 | 542 |
